Barbs Traded Over Glucose Strip Patent Royalties

Law360 (August 2, 2008, 12:00 AM EDT) -- A defense witness for Becton Dickinson & Co. and Nova Biomedical Corp. testified Monday that the companies should only have to pay $2.5 million in royalties if they are found to have infringed Abbott Laboratories' patent covering blood glucose monitoring test strips, as the trial in San Francisco federal court is wrapping up.

Jerry Hausman, a professor of economics at the Massachusetts Institute of Technology, told the jury that a 1% royalty on the defendants' net sales revenues from the allegedly infringing products would be reasonable...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.